329 related articles for article (PubMed ID: 15377673)
1. Identification of nonsteroidal anti-inflammatory drug-activated gene (NAG-1) as a novel downstream target of phosphatidylinositol 3-kinase/AKT/GSK-3beta pathway.
Yamaguchi K; Lee SH; Eling TE; Baek SJ
J Biol Chem; 2004 Nov; 279(48):49617-23. PubMed ID: 15377673
[TBL] [Abstract][Full Text] [Related]
2. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB
J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041
[TBL] [Abstract][Full Text] [Related]
3. Positive correlation between overexpression of phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma.
Khor TO; Gul YA; Ithnin H; Seow HF
Cancer Lett; 2004 Jul; 210(2):139-50. PubMed ID: 15183529
[TBL] [Abstract][Full Text] [Related]
4. Arrest of human lung fibroblasts in G2 phase after irradiation is regulated by converging phosphatidylinositol-3 kinase and beta1-integrin signaling in vitro.
Cordes N; van Beuningen D
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):453-62. PubMed ID: 14751515
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
[TBL] [Abstract][Full Text] [Related]
7. Cripto-1 induces phosphatidylinositol 3'-kinase-dependent phosphorylation of AKT and glycogen synthase kinase 3beta in human cervical carcinoma cells.
Ebert AD; Wechselberger C; Frank S; Wallace-Jones B; Seno M; Martinez-Lacaci I; Bianco C; De Santis M; Weitzel HK; Salomon DS
Cancer Res; 1999 Sep; 59(18):4502-5. PubMed ID: 10493495
[TBL] [Abstract][Full Text] [Related]
8. Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSF-1 activity.
Bijur GN; Jope RS
J Neurochem; 2000 Dec; 75(6):2401-8. PubMed ID: 11080191
[TBL] [Abstract][Full Text] [Related]
9. Alleviating the suppression of glycogen synthase kinase-3beta by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nuclei.
Salas TR; Reddy SA; Clifford JL; Davis RJ; Kikuchi A; Lippman SM; Menter DG
J Biol Chem; 2003 Oct; 278(42):41338-46. PubMed ID: 12900420
[TBL] [Abstract][Full Text] [Related]
10. Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta signaling pathway.
Pap M; Cooper GM
Mol Cell Biol; 2002 Jan; 22(2):578-86. PubMed ID: 11756553
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.
Lee YJ; Han HJ
Am J Physiol Renal Physiol; 2010 May; 298(5):F1263-75. PubMed ID: 20015942
[TBL] [Abstract][Full Text] [Related]
12. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle.
Horn S; Endl E; Fehse B; Weck MM; Mayr GW; Jücker M
Leukemia; 2004 Nov; 18(11):1839-49. PubMed ID: 15457186
[TBL] [Abstract][Full Text] [Related]
13. Protein breakdown in muscle from burned rats is blocked by insulin-like growth factor i and glycogen synthase kinase-3beta inhibitors.
Fang CH; Li BG; James JH; King JK; Evenson AR; Warden GD; Hasselgren PO
Endocrinology; 2005 Jul; 146(7):3141-9. PubMed ID: 15802492
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of proanthocyanidins on anoxia-reoxygenation injury of myocardial cells mediated by the PI3K/Akt/GSK-3β pathway and mitochondrial ATP-sensitive potassium channel.
Hu Y; Li L; Yin W; Shen L; You B; Gao H
Mol Med Rep; 2014 Oct; 10(4):2051-8. PubMed ID: 25109283
[TBL] [Abstract][Full Text] [Related]
15. Roles of Akt and glycogen synthase kinase 3beta in the ultraviolet B induction of cyclooxygenase-2 transcription in human keratinocytes.
Tang Q; Gonzales M; Inoue H; Bowden GT
Cancer Res; 2001 Jun; 61(11):4329-32. PubMed ID: 11389054
[TBL] [Abstract][Full Text] [Related]
16. Corneal cell survival in adenovirus type 19 infection requires phosphoinositide 3-kinase/Akt activation.
Rajala MS; Rajala RV; Astley RA; Butt AL; Chodosh J
J Virol; 2005 Oct; 79(19):12332-41. PubMed ID: 16160160
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1.
Seimi SK; Seinosuke K; Tsuyoshi S; Tomomi U; Tetsuaki H; Miki K; Ryuji T; Kenji I; Mitsuhiro Y
Circ J; 2004 Mar; 68(3):247-53. PubMed ID: 14993781
[TBL] [Abstract][Full Text] [Related]
18. Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responses.
Nair VD; Olanow CW
J Biol Chem; 2008 May; 283(22):15469-78. PubMed ID: 18387957
[TBL] [Abstract][Full Text] [Related]
19. Adenosine N1-Oxide Exerts Anti-inflammatory Effects through the PI3K/Akt/GSK-3β Signaling Pathway and Promotes Osteogenic and Adipocyte Differentiation.
Ohashi E; Kohno K; Arai N; Harashima A; Ariyasu T; Ushio S
Biol Pharm Bull; 2019; 42(6):968-976. PubMed ID: 31155593
[TBL] [Abstract][Full Text] [Related]
20. Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway.
Liang Y; Jing Z; Deng H; Li Z; Zhuang Z; Wang S; Wang Y
Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):70-5. PubMed ID: 25986738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]